Evidence map›Paper›PMID 36478350›Full record

ArticleJournal of pharmacokinetics and pharmacodynamics2023

A proof of concept reinforcement learning based tool for non parametric population pharmacokinetics workflow optimization.

J D Otalvaro, W M Yamada, A M Hernandez, A F Zuluaga, R Chen, M N Neely

Abstract read
In one paragraph

Article in Journal of pharmacokinetics and pharmacodynamics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Rising Role of Artificial Intelligence in Clinical Pharmacometrics and Model-Informed Precision Dosing in Pediatrics.The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG · 2026
    Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

J D OtalvaroLaboratory of Applied Pharmacokinetics and Bioinformatics, Department of Infectious Diseases, Children's Hospital Los Angeles, Los Angeles, CA, USA.
W M YamadaLaboratory of Applied Pharmacokinetics and Bioinformatics, Department of Infectious Diseases, Children's Hospital Los Angeles, Los Angeles, CA, USA.
A M HernandezBioinstrumentation and Clinical Engineering Research Group, Engineering Department, University of Antioquia, Medellín, Colombia.
A F ZuluagaLaboratory of Integrated and Specialized Medicine, Medical School, University of Antioquia, Medellín, Colombia.
R ChenLaboratory of Applied Pharmacokinetics and Bioinformatics, Department of Infectious Diseases, Children's Hospital Los Angeles, Los Angeles, CA, USA.
M N NeelyLaboratory of Applied Pharmacokinetics and Bioinformatics, Department of Infectious Diseases, Children's Hospital Los Angeles, Los Angeles, CA, USA. mneely@chla.usc.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The building of population pharmacokinetic models can be described as an iterative process in which given a model and a dataset, the pharmacometrician introduces some changes to the model specification, then perform an evaluation and based on the predictions obtained performs further optimization. This process (perform an action, witness a result, optimize your knowledge) is a perfect scenario for the implementation of Reinforcement Learning algorithms. In this paper we present the conceptual background and a implementation of one of those algorithms aiming to show pharmacometricians how to automate (to a certain point) the iterative model building process.We present the selected discretization for the action and the state space. SARSA (State-Action-Reward-State-Action) was selected as the RL algorithm to use, configured with a window of 1000 episodes with and a limit of 30 actions per episode. SARSA was configured to control an interface to the Non-Parametric Optimal Design algorithm, that was actually performing the parameter optimization.The Reinforcement Learning (RL) based agent managed to obtain the same likelihood and number of support points, with a distribution similar to the reported in the original paper. The total amount of time used by the train the agent was 5.5 h although we think this time can be further improved. It is possible to automatically find the structural model that maximizes the final likelihood for an specific pharmacokinetic dataset by using RL algorithm. The framework provided could allow the integration of even more actions i.e: add/remove covariates, non-linear compartments or the execution of secondary analysis. Many limitations were found while performing this study but we hope to address them all in future studies.

Indexed as

AlgorithmsReinforcement, PsychologyProbabilityWorkflowAutomationModelingModeling processPharmacokineticsReinforcement learning

Identifiers

PMID36478350
PMCPMC9938066

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.